These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 23201219)
1. Ocular experimental leishmaniasis in C57BL/10 and BALB/c mice induced by Leishmania amazonensis infection. Calabrese KS; Silva LS; Hardoim DJ; Souza CS; Abreu-Silva AL Exp Parasitol; 2013 Feb; 133(2):156-61. PubMed ID: 23201219 [TBL] [Abstract][Full Text] [Related]
2. Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host. Villaseñor-Cardoso MI; Salaiza N; Delgado J; Gutiérrez-Kobeh L; Pérez-Torres A; Becker I Parasite Immunol; 2008 Aug; 30(8):425-34. PubMed ID: 18507782 [TBL] [Abstract][Full Text] [Related]
3. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40. Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810 [TBL] [Abstract][Full Text] [Related]
4. Expression of infection-related genes in parasites and host during murine experimental infection with Leishmania (Leishmania) amazonensis. Pereira BA; Britto C; Alves CR Microb Pathog; 2012 Feb; 52(2):101-8. PubMed ID: 22178713 [TBL] [Abstract][Full Text] [Related]
5. Different patterns of disease in two inbred mouse strains infected with a clone of Leishmania mexicana amazonensis. Barral-Netto M; Cardoso SA; Barral A Acta Trop; 1987 Mar; 44(1):5-11. PubMed ID: 2884839 [TBL] [Abstract][Full Text] [Related]
6. Immunopathological studies of Leishmania amazonensis infection in resistant and in susceptible mice. de Oliveira Cardoso F; de Souza Cda S; Mendes VG; Abreu-Silva AL; Gonçalves da Costa SC; Calabrese KS J Infect Dis; 2010 Jun; 201(12):1933-40. PubMed ID: 20462353 [TBL] [Abstract][Full Text] [Related]
7. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages. Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349 [TBL] [Abstract][Full Text] [Related]
8. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice. Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242 [TBL] [Abstract][Full Text] [Related]
9. Leishmania amazonensis: humoral response to amastigote excreted-antigens in murine leishmaniasis. Hernández-Chinea C Exp Parasitol; 2007 Aug; 116(4):492-6. PubMed ID: 17349625 [TBL] [Abstract][Full Text] [Related]
10. In vivo near-infrared fluorescence imaging of Leishmania amazonensis expressing infrared fluorescence protein (iRFP) for real-time monitoring of cutaneous leishmaniasis in mice. Oliveira JC; da Silva AC; Oliveira RA; Pereira VR; Gil LH J Microbiol Methods; 2016 Nov; 130():189-195. PubMed ID: 27498229 [TBL] [Abstract][Full Text] [Related]
11. Leishmania (L.) amazonensis: fusion between parasitophorous vacuoles in infected bone-marrow derived mouse macrophages. Real F; Pouchelet M; Rabinovitch M Exp Parasitol; 2008 May; 119(1):15-23. PubMed ID: 18346736 [TBL] [Abstract][Full Text] [Related]
12. The histopathological and immunological pattern of CBA mice infected with Leishmania amazonensis after treatment with pyrazole carbohydrazide derivatives. Charret KS; Lagrota-Cândido J; Carvalho-Pinto CE; Hottz CF; Lira ML; Rodrigues RF; Gomes AO; Bernardino AM; Canto-Cavalheiro MM; Leon LL; Amaral VF Exp Parasitol; 2013 Feb; 133(2):201-10. PubMed ID: 23219949 [TBL] [Abstract][Full Text] [Related]
13. Histopathological studies of visceralized Leishmania (Leishmania) amazonensis in mice experimentally infected. Abreu-Silva AL; Calabrese KS; Cupolilo SM; Cardoso FO; Souza CS; Gonçalves da Costa SC Vet Parasitol; 2004 May; 121(3-4):179-87. PubMed ID: 15135858 [TBL] [Abstract][Full Text] [Related]
14. Parasitic load and histopathology of cutaneous lesions, lymph node, spleen, and liver from BALB/c and C57BL/6 mice infected with Leishmania mexicana. Aguilar Torrentera F; Lambot MA; Laman JD; Van Meurs M; Kiss R; Noël JC; Carlier Y Am J Trop Med Hyg; 2002 Mar; 66(3):273-9. PubMed ID: 12139220 [TBL] [Abstract][Full Text] [Related]
16. Leishmania (Leishmania) amazonensis infection in mice treated with FTY720. Lopes CT; de Paula DM; Cury PM; Valero-Lapchik VB; Bueno V Transplant Proc; 2010 Mar; 42(2):578-81. PubMed ID: 20304196 [TBL] [Abstract][Full Text] [Related]
17. Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin--than on footpad-infected mice. Felizardo TC; Gaspar-Elsas MI; Lima GM; Abrahamsohn IA Exp Parasitol; 2012 Jan; 130(1):48-57. PubMed ID: 22019418 [TBL] [Abstract][Full Text] [Related]
18. [Determination of the specificity of seric IgA produced in response to antigens of Leishmania (Leishmania) mexicana in murine leishmaniasis]. Pérez-Aguilar MC; Hernández O; Maizo de Segnini Z; Rojas CH; Díaz S; Alarcón M; Goncalves L Invest Clin; 2011 Sep; 52(3):216-29. PubMed ID: 21950193 [TBL] [Abstract][Full Text] [Related]
19. Infections in immunocompetent and immune-deficient mice with promastigotes of a North American isolate of Leishmania infantum. Rosypal AC; Zajac AM; Troy GC; Lindsay DS Vet Parasitol; 2005 Jun; 130(1-2):19-27. PubMed ID: 15893066 [TBL] [Abstract][Full Text] [Related]
20. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice. Almeida RP; Barral-Netto M; De Jesus AM; De Freitas LA; Carvalho EM; Barral A Am J Trop Med Hyg; 1996 Feb; 54(2):178-84. PubMed ID: 8619444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]